However, a study by Prevete et al. indicates that FPR1 functions as an antitumor agent by inhibiting angiogenesis in gastric cancer, as silencing it promotes tumor proliferation and enhances the response that favors angiogenesis [32]. This evidence concerns the gene FPR1 and neoplasm.